Which benefit from adding gemcitabine to vinorelbine in elderly (≥70 years) women with metastatic breast cancer? Early interruption of a phase II study
| Autor: | Basso, U. *, Fratino, L., Brunello, A., Lumachi, F., De Salvo, G.L., Lonardi, S., Ghiotto, C., Koussis, H., Pasetto, L.M., Monfardini, S. |
|---|---|
| Zdroj: | In Annals of Oncology January 2007 18(1):58-63 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|